Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Current Report · Items 2.02, 7.01, 9.01 · 8-K

Clorox Company

CLXNYSEEQUITYCurrent

Results of Operations and Financial Condition · Regulation FD Disclosure

Item 2.02 Results of Operations and Financial Condition On August 3, 2026, The Clorox Company issued a press release announcing its financial results for its fourth quarter and fiscal year ended June 30, 2026. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Filed Aug 3, 2026Accepted Aug 3, 2026, 4:12 PM EDTCIK 21076Accession 0000021076-26-000028
Share

Company context

The Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Headquartered in Oakland, California since 1913, Clorox integrates sustainability into how it does business. Driven by consumer-centric innovation, the company is committed to delivering clearly superior experiences through its trusted brands including Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr®, PineSol® and Purell® as well as international brands such as Chux®, Clorinda® and Poett®. Visit thecloroxcompany.com to learn more.

Current securities

Recent company filings

  1. 10-K filingAug 7, 2026
  2. 4 filingJul 17, 2026
  3. 4 filingJul 2, 2026
  4. 4 filingJul 2, 2026
  5. 4 filingJul 2, 2026

Disclosure sections

Items 2.02, 7.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 2.02Item 2.02 - Results of Operations
Item 2.02 Results of Operations and Financial Condition On August 3, 2026, The Clorox Company issued a press release announcing its financial results for its fourth quarter and fiscal year ended June 30, 2026. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure Attached hereto as Exhibit 99.2 and incorporated herein by reference is supplemental financial information.
Filed exhibits (2)
EX-99.1 (by filename) ex991-pressreleasedatedaug.htm

EX-99.1 2 ex991-pressreleasedatedaug.htm EX-99.1 Document Clorox Reports Q4 and FY26 Results, Provides FY27 Outlook Delivers Q4 results in line with expectations while advancing strategic investments ─────────────────────────────────────────────────────────────────────────────────────── OAKLAND, California, Aug. 3, 2026 - The Clorox Company (NYSE: CLX) today reported results for the fourth quarter and fiscal year 2026, which ended June 30, 2026. Fourth-Quarter Fiscal Year 2026 Summary In April 2026, the company completed the acquisition of GOJO Industries, Inc. (GOJO), which now operates as Clorox Purell and includes the Purell® brand and a portfolio of health and hygiene solutions. The following is a summary of key fourth-quarter results. All comparisons are with the fourth quarter of fiscal year 2025 unless otherwise stated. • Net sales decreased 2% to $1.95 billion. The GOJO acquisition added about 10 points. Organic sales1 decreased 13%, primarily due to lapping the incremental shipments related to the ERP transition, which is about 13.5 points. • Gross margin decreased 520 basis points to 41.3% from 46.5%, primarily driven by lower volume, impact from the inven…

Open exhibit ↗
EX-99.2 (by filename) ex992-supplementalinformat.htm

EX-99.2 3 ex992-supplementalinformat.htm EX-99.2 Document Three months ended June 30, 2026 Percentage change versus the year-ago period ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Reported Reported Volume Acquisitions & Divestitures (1) Foreign Exchange Impact Price Organic Organic (GAAP) Mix and Sales Volume (4) Net Sales Other (2) Growth / (Decrease) Growth / (Decrease) (Non-GAAP) (3) Health …

Open exhibit ↗